Epicare Pharma Private Limited
About Epicare Pharma Private Limited
Data last updated:
Epicare Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 17 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC286832. Its GSTIN is 27AAECE5294R1ZT (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pramod Nehalsingh Bisen and Swapnil Ramkishor Jaiswal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No.6635/A P No.173 Aradhana Nagar, Nagpur, Maharashtra, India – 440027.
As per the financials filed for FY 2025, the company reported a revenue of ₹45.2 Lakh, a growth of 83% compared to the previous year. For the same year it recorded a net profit of ₹1.13 Lakh (net margin 2.5%) and EBITDA of ₹1.19 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 66% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH No.6635/A P No.173 Aradhana Nagar, Nagpur, Maharashtra, India – 440027
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Epicare Pharma Private Limited
The main business activity of Epicare Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Epicare Pharma Private Limited FY 2025 filings available
Epicare Pharma Private Limited reported revenue of ₹45.2 Lakh (up 83% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Epicare Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 66% over three years, including 83% growth in the latest year. EBITDA rose 811% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Epicare Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.19 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.13 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Epicare Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Epicare Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Epicare Pharma Private Limited
Epicare Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shinzo Pharma Private Limited | ₹46.44 Lakh (FY 2024) | •••• | •••• | -57.0% | •••• | Solan, Himachal Pradesh, India |
| View Coatings Private Limited | ₹46.35 Lakh (FY 2025) | •••• | •••• | -31.0% | •••• | Kolhapur, Maharashtra, India |
| Gelidcure Healthcare Private Limited | ₹46.23 Lakh (FY 2025) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Apex Medical Systems Private Limited | ₹45.86 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | New Delhi, Delhi, India |
| SVV Nutrition Private Limited | ₹45.41 Lakh (FY 2025) | •••• | •••• | 67.0% | •••• | Ballabgarh, Haryana, India |
| Epicare Pharma Private Limited this company | ₹45.2 Lakh (FY 2025) | •••• | •••• | 83.0% | •••• | Nagpur, Maharashtra, India |
| Liquidseal India Private Limited | ₹44.7 Lakh (FY 2025) | •••• | •••• | 48223.0% | •••• | Pune, Maharashtra, India |
| Lorfin Lifescience Private Limited | ₹43.96 Lakh (FY 2025) | •••• | •••• | 241.0% | •••• | Ahmedabad, Gujarat, India |
| Noble Life Energy Private Limited | ₹43.46 Lakh (FY 2023) | •••• | •••• | 51.0% | •••• | Pune, Maharashtra, India |
| Truswel Pharmaceuticals Private Limited | ₹43.2 Lakh (FY 2025) | •••• | •••• | 1352.0% | •••• | Navi Mumbai, Maharashtra, India |
| Dermaventure Private Limited | ₹42.8 Lakh (FY 2025) | •••• | •••• | 93.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Epicare Pharma by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Epicare Pharma Private Limited
Epicare Pharma Private Limited is audited by RITESHRAJESHMEHTA for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RITESHRAJESHMEHTA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Epicare Pharma Private Limited
Epicare Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramod Nehalsingh Bisen | Director | 17 Oct 2016 | 9 Years 11 Months | Current |
| Swapnil Ramkishor Jaiswal | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
Ownership and Shareholding of Epicare Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Epicare Pharma Private Limited
Epicare Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Epicare Pharma Private Limited
Employment history and EPFO contributions of people linked to Epicare Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Epicare Pharma Private Limited
Epicare Pharma Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Shamsunder Suryakant Jagdale ceased to be Director on 04 Mar 2019.
Credit Ratings, Litigation & Regulatory Alerts for Epicare Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Epicare Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Epicare Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Epicare Pharma Private Limited
Epicare Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECE5294R1ZT | Maharashtra | Active | 12 Feb 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Epicare Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epicare Pharma Private Limited
Epicare Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 17 October 2016 (10+ years old) and is registered under CIN U74999MH2016PTC286832.
Epicare Pharma reported revenue of ₹45.2 Lakh for FY 2025 (up 83% YoY).
Epicare Pharma has 2 current directors:
- Pramod Nehalsingh Bisen - Director
- Swapnil Ramkishor Jaiswal - Director
Epicare Pharma reported a net profit of ₹1.13 Lakh (net margin 2.5%) and EBITDA of ₹1.19 Lakh (EBITDA margin 2.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Epicare Pharma is 66% over three years. In the latest year (FY 2025) revenue rose 83%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Epicare Pharma is 27AAECE5294R1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Epicare Pharma is U74999MH2016PTC286832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Epicare Pharma was incorporated on 17 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Epicare Pharma by revenue are Shinzo Pharma Private Limited, View Coatings Private Limited, Gelidcure Healthcare Private Limited, Apex Medical Systems Private Limited, SVV Nutrition Private Limited and 5 more, all in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations).
Shamsunder Suryakant Jagdale ceased to be Director on 04 Mar 2019. Swapnil Ramkishor Jaiswal was appointed as Director on 01 Jun 2017. Niranjan Vijayrao Deshmukh ceased to be Director on 01 Jan 2017. Epicare Pharma has 5 board changes on record in total.
The registered office of Epicare Pharma is at H No.6635A P No.173 Aradhana Nagar, Nagpur, Maharashtra, India – 440027.